Overview
- Only 18.7% of the 12.76 million adults eligible under USPSTF criteria were up to date with screening in 2024.
- At current uptake, the study estimates about 14,970 lung cancer deaths prevented and 190,030 life-years gained over five years.
- Modeling suggests 100% uptake among eligible adults could prevent roughly 62,110 deaths and yield about 872,270 life-years over five years.
- The analysis used 2024 National Health Interview Survey data with two validated predictive models, with uptake lowest at ages 50–54 (7.9%) and highest at 70–80 (22.8%).
- An accompanying JAMA editorial and ACS/ACS CAN statements call for a national push to raise participation, expand eligibility regardless of years since quitting, and eliminate patient costs.